Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

1 terminated/withdrawn out of 18 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
7(50.0%)
Phase 2
4(28.6%)
Phase 1
2(14.3%)
Phase 4
1(7.1%)
14Total
N/A(7)
Phase 2(4)
Phase 1(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT05909930Not ApplicableSuspended

Effectiveness of TheRApeutic ExercIse aNd EDucation on Patients With Massive Rotator Cuff Tears

Role: collaborator

NCT05909865Not ApplicableSuspended

PRedIcting MEniscal Tears Outcomes After Physical Therapy Treatment

Role: collaborator

NCT05913050Not ApplicableSuspended

Predicting ROtator Cuff Tears Outcomes After Physical Therapy Treatment

Role: collaborator

NCT05733377Recruiting

Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome

Role: collaborator

NCT05250648Phase 4Recruiting

Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)

Role: lead

NCT05334173Not ApplicableActive Not Recruiting

Gastric Bypass With Different Lengths of the Bilipancreatic Limb

Role: lead

NCT03773445Completed

Golimumab Trough Levels in Patients With Ulcerative Colitis

Role: collaborator

NCT03114618Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Role: collaborator

NCT05027412Not ApplicableUnknown

En Bloc TURBT With Collins Loop vs Conventional TURBT

Role: lead

NCT04346147Phase 2Unknown

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19

Role: lead

NCT02795650Phase 2Unknown

Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation

Role: lead

NCT04017481Not ApplicableCompleted

Non Invasive Neuromodulation for Patients With Motor Control Disorders

Role: collaborator

NCT03936244Not ApplicableCompleted

Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms

Role: lead

NCT01548924Phase 1Terminated

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Role: collaborator

NCT01484080Phase 1Completed

Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates

Role: collaborator

NCT01744717Completed

Validation of "Escala de Conductas Indicadoras de Dolor" ESCID Scale for Measuring Pain in Critically Ill Patients

Role: collaborator

NCT01454180Phase 2Completed

Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets

Role: collaborator

NCT01703910Phase 2Completed

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

Role: collaborator

All 18 trials loaded